Literature DB >> 10896427

Organ transplantation and discrimination. Treatment should be available to everyone.

P Byrne.   

Abstract

Mesh：

Year:  2000        PMID： 10896427      PMCID： PMC1127379     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Psychosocial factors in selection for liver transplantation. Need to be explicitly assessed and managed.

Authors:  G Masterton
Journal:  BMJ       Date:  2000-01-29

2.  Position statement on discrimination against persons with previous psychiatric treatment.

Authors: 
Journal:  Am J Psychiatry       Date:  1997-07       Impact factor: 18.112

Review 3.  Psychosocial assessment of organ transplant candidates and the Americans with Disabilities Act.

Authors:  D Orentlicher
Journal:  Gen Hosp Psychiatry       Date:  1996-11       Impact factor: 3.238

4.  Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization.

Authors:  R W McGory; M B Ishitani; W M Oliveira; W C Stevenson; C S McCullough; R C Dickson; S H Caldwell; T L Pruett
Journal:  Transplantation       Date:  1996-05-15       Impact factor: 4.939

5.  Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis.

Authors:  L Grellier; D Mutimer; M Ahmed; D Brown; A K Burroughs; K Rolles; P McMaster; P Beranek; F Kennedy; H Kibbler; P McPhillips; E Elias; G Dusheiko
Journal:  Lancet       Date:  1996-11-02       Impact factor: 79.321

6.  Psychosocial evaluation of organ transplant candidates. A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation.

Authors:  J L Levenson; M E Olbrisch
Journal:  Psychosomatics       Date:  1993 Jul-Aug       Impact factor: 2.386

7.  Psychiatric evaluation and outcomes in candidates for heart transplantation.

Authors:  L Phipps
Journal:  Clin Invest Med       Date:  1997-12       Impact factor: 0.825

8.  Liver transplantation in European patients with the hepatitis B surface antigen.

Authors:  D Samuel; R Muller; G Alexander; L Fassati; B Ducot; J P Benhamou; H Bismuth
Journal:  N Engl J Med       Date:  1993-12-16       Impact factor: 91.245

9.  Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation.

Authors:  J R Nery; D Weppler; M Rodriguez; P Ruiz; E R Schiff; A G Tzakis
Journal:  Transplantation       Date:  1998-06-27       Impact factor: 4.939
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.